Treatment-Resistant Depressive Disorder in Adults

January 06, 2017

Location: Hartford Hospital's Institute of Living

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 18-64 years of age for a 12-month double-blind and open-label study for the treatment major depressive disorder using an add-on medication with an anti-depressant treatment.

For more information about this trial, please contact:

Dr. John W. Goethe and Dr. Andrew Winokur
Phone: 860.545.7502
Email: clinical.trials@hhchealth.org